NCT03697525

Brief Summary

prospective randomized double-blind sham-controlled study aimed to investigate the effects of Repeated Muscle Vibration (rMV) on motor recovery in acute stroke patients, treated within 72 hours from symptoms onset

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

2.5 years

First QC Date

September 29, 2018

Last Update Submit

March 24, 2020

Conditions

Keywords

repetitive muscle vibration (rMV)acute strokemotor recoverynonpharmacological therapybedside intervention

Outcome Measures

Primary Outcomes (1)

  • Motor Recovery

    Motor recovery is expressed as the differences over time (from T-0 to T-1) between the two groups concerning Motricity Index scale scores. The Motricity Index is an ordinal scale that evaluates motor skills and functional limbs in patients with neurological diseases. The movements object of the evaluation are in total 6 (3 for each limb) The scores range from 0 (i.e. no movement) to 33 (ie normal movements) for a maximum of 100 for each limb.

    4 ± 1 days

Secondary Outcomes (3)

  • Motor Recovery within/associated to synergies

    4 ± 1 days

  • Stroke Recovery

    4 ± 1 days

  • Spasticity Recovery

    4 ± 1 days

Study Arms (2)

Vibration Group (VG)

EXPERIMENTAL

VG participants undergo rMV treatment, carried out for three consecutive days by 2 trained physiatrists; each daily session consists of three 10-minute treatment (for each treated limb), interspersed with a 5-minute break. During the rMV, subjects are required to make a voluntary isometric contraction of the treated muscle

Device: Vibration

Control Group (CG)

SHAM COMPARATOR

CG participants undergo the sham rMV by positioning the vibrator close to the tendon but without touching the skin. In this condition, patients were only subject to the faint buzzing sound of the vibrator. Sham rMV treatment is carried out for three consecutive days by 2 trained physiatrists; each daily session consists of three 10-minute treatment (for each treated limb), interspersed with a 5-minute break. During the rMV, subjects are required to make a voluntary isometric contraction of the treated muscle

Device: Vibration

Interventions

VibrationDEVICE

Low-amplitude rMV (frequency 100 Hz; amplitude range 0.2-0.5 mm) is applied over the flexor carpi radialis and the biceps brachii for the upper limb treatment, and/or over the quadriceps femoris for the lower limb treatment, by means of a specific commercial device (Cro®System, NEMOCOsrl).

Also known as: Repeated (focal) Muscle Vibration (rMV)
Control Group (CG)Vibration Group (VG)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>18,
  • first ever stroke detected by Magnetic Resonance Imaging (MRI) or Computer Tomography (CT) scan
  • ischemic or hemorrhagic stroke within 72 hours from symptom onset
  • motor deficit of the upper and/or lower limb;
  • ability to perform at least a minimal isometric voluntary contraction of the affected limb

You may not qualify if:

  • TIA, or rapidly improving stroke
  • cerebral venous thrombosis
  • patients presenting with aphasia, neglect, or apraxia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Human Neurosciences, "Sapienza" University of Rome

Rome, 00184, Italy

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Vittorio Di Piero, Prof

    Università di Roma La Sapienza

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
double-blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective randomized double-blind sham-controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 29, 2018

First Posted

October 5, 2018

Study Start

January 1, 2016

Primary Completion

July 1, 2018

Study Completion

March 1, 2020

Last Updated

March 25, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations